AHCC 03
Find out about the AHCC 03 trial, a completed study on adjuvant intra-arterial radioactive iodine after liver cancer surgery, including its findings and key investigators.
Trial summary of AHCC 03
AHCC 03 | Randomised Trial of Adjuvant Intra-Arterial Radio-Active Iodine after Curative Resection of Hepatocellular Carcinoma |
|---|---|
Status | Completed in March 2007 with recruitment of 103 patients. Published inWorld J Surg 6 March 2013: 1-6. |
Contributing Principal Investigators and Centres | Pierce Chow (SGH, Singapore), Lucien Ooi (NCC, Singapore), Tay Khoon Hean (CGH, Singapore), Chew Soo Ping (TTSH, Singapore) |
Protocol Chair | Alexander Chung alexander.chung.y.f@singhealth.com.sg |
